TY - JOUR
T1 - Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa
T2 - a multicentre observational study
AU - Cloete, Jeané
AU - Kruger, Annelet
AU - Masha, Maureen
AU - du Plessis, Nicolette M.
AU - Mawela, Dini
AU - Tshukudu, Mphailele
AU - Manyane, Tabea
AU - Komane, Lekwetji
AU - Venter, Marietjie
AU - Jassat, Waasila
AU - Goga, Ameena
AU - Feucht, Ute
N1 - Funding Information:
We thank Tshwane District management team; the health-care workers at public sector hospitals in Tshwane District (especially L Chumba, N Singh, M Maharaj, J Talma, D Kutumela, and V Zulu); the staff at Tshwane District Health Services responsible for COVID-19 surveillance (especially M Moshime-Shabangu); Tshwane District Clinical Specialist Team members (especially R Skhosana); DATCOV team (especially R Welch); South African Medical Research Council research staff (especially C Chabalala); the laboratory teams at the ZARV, Department of Medical Virology, University of Pretoria (especially M Davids, A Mendes, and A Strydom); and the National Health Laboratory Service Tshwane Academic division, Department Medical Virology, University of Pretoria and members of NGS-SA for sequencing information. The South African Medical Research Council funds the SA COVID Kids study and staff time (AG). The ZARV programme is funded through the African Network for improved Diagnostics, Epidemiology and Management of Common Infectious Agents, COVID-19 fund, G7 global Health Fund. NGS-SA is funded by the Department of Science and Innovation and the South African Medical Research Council.
Funding Information:
We thank Tshwane District management team; the health-care workers at public sector hospitals in Tshwane District (especially L Chumba, N Singh, M Maharaj, J Talma, D Kutumela, and V Zulu); the staff at Tshwane District Health Services responsible for COVID-19 surveillance (especially M Moshime-Shabangu); Tshwane District Clinical Specialist Team members (especially R Skhosana); DATCOV team (especially R Welch); South African Medical Research Council research staff (especially C Chabalala); the laboratory teams at the ZARV, Department of Medical Virology, University of Pretoria (especially M Davids , A Mendes, and A Strydom); and the National Health Laboratory Service Tshwane Academic division, Department Medical Virology, University of Pretoria and members of NGS-SA for sequencing information. The South African Medical Research Council funds the SA COVID Kids study and staff time (AG). The ZARV programme is funded through the African Network for improved Diagnostics, Epidemiology and Management of Common Infectious Agents, COVID-19 fund, G7 global Health Fund. NGS-SA is funded by the Department of Science and Innovation and the South African Medical Research Council.
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/5
Y1 - 2022/5
N2 - Background: South Africa reported a notable increase in COVID-19 cases from mid-November, 2021, onwards, starting in Tshwane District, which coincided with the rapid community spread of the SARS-CoV-2 omicron (B.1.1.529) variant. This increased infection rate coincided with a rapid increase in paediatric COVID-19-associated admissions to hospital (hereafter referred to as hospitalisations). Methods: The Tshwane Maternal-Child COVID-19 study is a multicentre observational study in which we investigated the clinical manifestations and outcomes of paediatric patients (aged ≤19 years) who had tested positive for SARS-CoV-2 and were admitted to hospital for any reason in Tshwane District during a 6-week period at the beginning of the fourth wave of the COVID-19 epidemic in South Africa. We used five data sources, which were: (1) COVID-19 line lists; (2) collated SARS-CoV-2 testing data; (3) SARS-CoV-2 genomic sequencing data; (4) COVID-19 hospitalisation surveillance; and (5) clinical data of public sector COVID-19-associated hospitalisations among children aged 13 years and younger. Findings: Between Oct 31 and Dec 11, 2021, 6287 children and adolescents in Tshwane District were recorded as having COVID-19. During this period, 2550 people with COVID-19 were hospitalised, of whom 462 (18%) were aged 19 years or younger. The number of paediatric cases was higher than in the three previous SARS-CoV-2 waves, uncharacteristically increasing ahead of adult hospitalisations. 75 viral samples from adults and children in the district were sequenced, of which 74 (99%) were of the omicron variant. Detailed clinical notes were available for 138 (75%) of 183 children aged ≤13 years with COVID-19 who were hospitalised. 87 (63%) of 138 children were aged 0–4 years. In 61 (44%) of 138 cases COVID-19 was the primary diagnosis, among whom symptoms included fever (37 [61%] of 61), cough (35 [57%]), shortness of breath (19 [31%]), seizures (19 [31%]), vomiting (16 [26%]), and diarrhoea (15 [25%]). Median length of hospital stay was 2 days [IQR 1–3]). 122 (88%) of 138 children with available data needed standard ward care and 27 (20%) needed oxygen therapy. Seven (5%) of 138 children were ventilated and four (3%) died during the study period, all related to complex underlying copathologies. All children and 77 (92%) of 84 parents or guardians with available data were unvaccinated to COVID-19. Interpretation: Rapid increases in paediatric COVID-19 cases and hospitalisations mirror high community transmission of the SARS-CoV-2 omicron variant in Tshwane District, South Africa. Continued monitoring is needed to understand the long-term effect of the omicron variant on children and adolescents. Funding: South African Medical Research Council, South African Department of Science & Innovation, G7 Global Health Fund.
AB - Background: South Africa reported a notable increase in COVID-19 cases from mid-November, 2021, onwards, starting in Tshwane District, which coincided with the rapid community spread of the SARS-CoV-2 omicron (B.1.1.529) variant. This increased infection rate coincided with a rapid increase in paediatric COVID-19-associated admissions to hospital (hereafter referred to as hospitalisations). Methods: The Tshwane Maternal-Child COVID-19 study is a multicentre observational study in which we investigated the clinical manifestations and outcomes of paediatric patients (aged ≤19 years) who had tested positive for SARS-CoV-2 and were admitted to hospital for any reason in Tshwane District during a 6-week period at the beginning of the fourth wave of the COVID-19 epidemic in South Africa. We used five data sources, which were: (1) COVID-19 line lists; (2) collated SARS-CoV-2 testing data; (3) SARS-CoV-2 genomic sequencing data; (4) COVID-19 hospitalisation surveillance; and (5) clinical data of public sector COVID-19-associated hospitalisations among children aged 13 years and younger. Findings: Between Oct 31 and Dec 11, 2021, 6287 children and adolescents in Tshwane District were recorded as having COVID-19. During this period, 2550 people with COVID-19 were hospitalised, of whom 462 (18%) were aged 19 years or younger. The number of paediatric cases was higher than in the three previous SARS-CoV-2 waves, uncharacteristically increasing ahead of adult hospitalisations. 75 viral samples from adults and children in the district were sequenced, of which 74 (99%) were of the omicron variant. Detailed clinical notes were available for 138 (75%) of 183 children aged ≤13 years with COVID-19 who were hospitalised. 87 (63%) of 138 children were aged 0–4 years. In 61 (44%) of 138 cases COVID-19 was the primary diagnosis, among whom symptoms included fever (37 [61%] of 61), cough (35 [57%]), shortness of breath (19 [31%]), seizures (19 [31%]), vomiting (16 [26%]), and diarrhoea (15 [25%]). Median length of hospital stay was 2 days [IQR 1–3]). 122 (88%) of 138 children with available data needed standard ward care and 27 (20%) needed oxygen therapy. Seven (5%) of 138 children were ventilated and four (3%) died during the study period, all related to complex underlying copathologies. All children and 77 (92%) of 84 parents or guardians with available data were unvaccinated to COVID-19. Interpretation: Rapid increases in paediatric COVID-19 cases and hospitalisations mirror high community transmission of the SARS-CoV-2 omicron variant in Tshwane District, South Africa. Continued monitoring is needed to understand the long-term effect of the omicron variant on children and adolescents. Funding: South African Medical Research Council, South African Department of Science & Innovation, G7 Global Health Fund.
UR - http://www.scopus.com/inward/record.url?scp=85125748241&partnerID=8YFLogxK
U2 - 10.1016/S2352-4642(22)00027-X
DO - 10.1016/S2352-4642(22)00027-X
M3 - Article
C2 - 35189083
AN - SCOPUS:85125748241
SN - 2352-4642
VL - 6
SP - 294
EP - 302
JO - The Lancet Child and Adolescent Health
JF - The Lancet Child and Adolescent Health
IS - 5
ER -